Overview of the progress and prospects of SMAC mimetics in cancers: Is it a silver bullet?
Loss of apoptosis results in the survival and uncontrolled proliferation of cancer cells. Basic and clinical researchers have dissected myriads of central regulators of apoptosis. Second mitochondria-derived activator of caspases (SMAC)/ direct inhibitor of apoptosis protein (IAP)-binding protein wi...
Saved in:
Main Authors: | Almuradova Elvina (Author), Malik Durr- (Author), Yousaf Sara (Author), Farooqi Ammad Ahmad (Author) |
---|---|
Format: | Book |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Silver Bullet
by: Hume, Fergus, 1859-1932 -
Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019) -
The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP
by: Huang Q, et al.
Published: (2019) -
Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents
by: Nevine M.Y. Elsayed, et al.
Published: (2015) -
Is Silver the Ultimate Antimicrobial Bullet?
by: Raymond J Turner
Published: (2018)